V

VCYT

VCYT

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
VCYT Live QuoteReal-time
$25.04
$21.18(-45.82%)1M
Day Range$24.95 – $26.63
Open$25.87
Previous Close$25.57
Volume1.87M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$2.02B
P/E Ratio (TTM)16.3
Forward P/E13.8
EPS (TTM)$1.54
Price to Book1.4
Dividend Yield0.65%
Beta (Volatility)1.96
IndustryDIAGNOSTICS & RESEARCH
52-Week RangeCurrent: $25.04 (8%)
Low: $21.91High: $60.91
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$41.60-72.3% upside

Insider Buys

0

$0

Insider Sales

60

$29.76M

Total Volume

$29.76M

96 transactions

Net Activity

$29.76M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
S
1

Stapley Marc

CEO

0 buys6 sells

$11.15M total

E
2

Eastham Karin

Dir

0 buys7 sells

$3.33M total

M
3

McGuire Annie

EVP, GC

0 buys11 sells

$2.74M total

C
4

Chambers Rebecca

CFO

0 buys7 sells

$2.23M total

J
5

Jones Evan/ Fa

Dir

0 buys2 sells

$2.00M total

Trading History
VCYT insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 27, 2026

3 weeks ago

Eastham Karin

Dir

Director
Sell14.8K$50.00$743K

Sep 24, 2026

1 months ago

Holstein Jens

Dir

Director
Sell15.0K$48.50$728K

Oct 19, 2026

1 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell40.9K$-1864.00$0

Oct 19, 2026

1 months ago

Bhanji Muna

Dir

Director
Sell1.9K$43.70$81K

Sep 21, 2026

2 months ago

Leite John

Global Chief Commercial Off

C-Level
Sell4.0K$40.00$161K

Sep 21, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell124.3K$-4015.00$0

Sep 14, 2026

2 months ago

Holstein Jens

Dir

Director
Sell5.0K$40.95$205K

Sep 14, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell27.5K$-5000.00$0

Sep 4, 2026

2 months ago

McGuire Annie

EVP, GC

EVP
Sell3.3K$43.09$140K

Sep 4, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell133.0K$-13110.00$0

Sep 4, 2026

2 months ago

Febbo Phillip G.

Chief Scientific, Med Officer

C-Level
Sell13.1K$43.05$564K

Sep 4, 2026

2 months ago

Chambers Rebecca

CFO

CFO
Sell3.7K$43.10$157K

Sep 1, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell42.7K$-1864.00$0

Sep 1, 2026

2 months ago

Bhanji Muna

Dir

Director
Sell1.9K$42.97$80K

Jun 18, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell15.1K$-3729.00$0

Jun 18, 2026

5 months ago

Eastham Karin

Dir

Director
Sell3.7K$52.89$197K

Jun 4, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell137.2K$-3176.00$0

Jun 4, 2026

5 months ago

Leite John

Global Chief Commercial Off

C-Level
Sell14.0K$50.07$700K

Jun 4, 2026

5 months ago

McGuire Annie

EVP, GC

EVP
Sell3.2K$49.76$158K

Jun 4, 2026

5 months ago

Chambers Rebecca

CFO

CFO
Sell3.6K$49.73$177K

Jun 4, 2026

5 months ago

Stapley Marc

CEO

CEO
Sell138.1K$50.12$6.92M

May 22, 2026

6 months ago

Wygant Jonathan

VP, Chief Accounting Officer

VP
Sell24.0K$45.40$1.09M

May 22, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell45.4K$-24000.00$0

May 20, 2026

6 months ago

Epstein Robert S

Dir

Director
Sell10.0K$44.01$440K

May 20, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell52.4K$-10000.00$0

May 6, 2026

6 months ago

McGuire Annie

SVP, GC

SVP
Sell10.2K$39.03$398K

May 6, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell143.7K$-10204.00$0

Mar 4, 2026

8 months ago

McGuire Annie

SVP, GC

SVP
Sell6.7K$35.55$237K

Mar 4, 2026

8 months ago

Stapley Marc

CEO

CEO
Sell45.5K$35.97$1.64M

Mar 4, 2026

8 months ago

Chambers Rebecca

CFO

CFO
Sell18.3K$36.14$663K

Mar 4, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell131.2K$-18341.00$0

Mar 4, 2026

8 months ago

Leite John

Chief Commercial Officer-CLIA

C-Level
Sell5.3K$35.19$185K

Mar 2, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell117.3K$-13425.00$0

Mar 2, 2026

8 months ago

Febbo Phillip G.

Chief Scientific, Med Officer

C-Level
Sell13.4K$36.16$485K

Dec 16, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell67.8K$-10739.00$0

Dec 16, 2025

11 months ago

McGuire Annie

SVP, GC

SVP
Sell10.7K$43.13$463K

Dec 5, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell13.6K$-20000.00$0

Dec 5, 2025

11 months ago

Eastham Karin

Dir

Director
Sell20.0K$45.45$909K

Dec 4, 2025

11 months ago

Leite John

Chief Commercial Officer-CLIA

C-Level
Sell1.3K$47.51$61K

Dec 4, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell78.5K$-1422.00$0

Dec 4, 2025

11 months ago

McGuire Annie

SVP, GC

SVP
Sell1.4K$47.30$67K

Dec 4, 2025

11 months ago

Chambers Rebecca

CFO

CFO
Sell13.3K$46.84$622K

Dec 4, 2025

11 months ago

Stapley Marc

CEO

CEO
Sell7.7K$47.09$361K

Nov 25, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell86.3K$-2808.00$0

Nov 25, 2025

12 months ago

Jones Evan/ Fa

Dir

Director
Sell1.1K$50.25$56K

Nov 25, 2025

12 months ago

Leite John

Chief Commercial Officer-CLIA

C-Level
Sell2.8K$50.00$140K

Nov 20, 2025

12 months ago

Holstein Jens

Dir

Director
Sell10.0K$42.36$424K

Nov 20, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell27.2K$-10000.00$0

Nov 7, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell38.7K$-10920.00$0

Nov 7, 2025

12 months ago

Wygant Jonathan

VP, Chief Accounting Officer

VP
Sell10.9K$41.20$450K

Nov 5, 2025

12 months ago

McGuire Annie

SVP, GC

SVP
Sell6.5K$40.00$259K

Nov 5, 2025

12 months ago

Jones Evan/ Fa

Dir

Director
Sell43.2K$45.06$1.95M

Nov 5, 2025

12 months ago

Chambers Rebecca

CFO

CFO
Sell7.0K$41.00$287K

Nov 5, 2025

12 months ago

Eastham Karin

Dir

Director
Sell9.7K$40.02$387K

Nov 5, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell83.0K$-6466.00$0

Oct 6, 2025

13 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell92.4K$-8349.00$0

Oct 6, 2025

13 months ago

Febbo Phillip G.

Chief Scientific, Med Officer

C-Level
Sell8.3K$36.02$301K

Oct 1, 2025

13 months ago

McGuire Annie

SVP, GC

SVP
Sell2.2K$35.00$76K

Oct 1, 2025

13 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell89.1K$-2539.00$0

Oct 1, 2025

13 months ago

Leite John

Chief Commercial Officer-CLIA

C-Level
Sell2.5K$35.00$89K

Oct 1, 2025

13 months ago

Epstein Robert S

Dir

Director
Sell21.5K$35.08$753K

Sep 19, 2025

14 months ago

McGuire Annie

SVP, GC

SVP
Sell2.3K$33.69$77K

Sep 19, 2025

14 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell91.6K$-2283.00$0

Sep 4, 2025

14 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell334.2K$-7667.00$0

Sep 4, 2025

14 months ago

Stapley Marc

CEO

CEO
Sell7.7K$30.41$233K

Jun 13, 2025

17 months ago

Eastham Karin

Dir

Director
Sell4.6K$26.66$122K

Jun 13, 2025

17 months ago

Bhanji Muna

Dir

Director
Sell4.6K$26.67$122K

Jun 13, 2025

17 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell13.9K$-4590.00$0

Jun 4, 2025

17 months ago

Leite John

Chief Commercial Officer-CLIA

C-Level
Sell2.8K$27.20$76K

Jun 4, 2025

17 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell94.5K$-2809.00$0

Mar 7, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell100.2K$-7411.00$0

Mar 7, 2025

20 months ago

Leite John

Chief Commercial Officer-CLIA

C-Level
Sell7.4K$31.66$235K

Mar 4, 2025

20 months ago

Febbo Phillip G.

Chief Scientific, Med Officer

C-Level
Sell8.0K$33.35$268K

Mar 4, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell82.5K$-8037.00$0

Mar 4, 2025

20 months ago

Stapley Marc

CEO

CEO
Sell52.7K$33.34$1.76M

Mar 4, 2025

20 months ago

McGuire Annie

SVP, GC

SVP
Sell1.1K$33.69$38K

Feb 27, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell71.4K$-5746.00$0

Feb 27, 2025

21 months ago

Leite John

Chief Commercial Officer-CLIA

C-Level
Sell5.7K$33.84$194K

Feb 3, 2025

21 months ago

Chambers Rebecca

CFO

CFO
Sell527$43.85$23K

Feb 3, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell113.5K$-527.00$0

Jan 2, 2025

22 months ago

Eastham Karin

Dir

Director
Sell10.0K$40.30$403K

Jan 2, 2025

22 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell18.5K$-10000.00$0

Dec 13, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell307.3K$-5590.00$0

Dec 13, 2024

23 months ago

Stapley Marc

CEO

CEO
Sell5.6K$43.42$243K

Dec 4, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell82.4K$-3934.00$0

Dec 4, 2024

23 months ago

McGuire Annie

SVP, GC

SVP
Sell18.7K$44.02$823K

Dec 4, 2024

23 months ago

Febbo Phillip G.

Chief Scientific, Med Officer

C-Level
Sell3.9K$44.09$173K

Dec 3, 2024

23 months ago

Wygant Jonathan

VP, Chief Accounting Officer

VP
Sell956$43.36$41K

Dec 3, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell73.8K$-1050.00$0

Dec 3, 2024

23 months ago

Leite John

Chief Commercial Officer-CLIA

C-Level
Sell1.1K$43.25$45K

Dec 3, 2024

23 months ago

Chambers Rebecca

CFO

CFO
Sell7.0K$43.23$303K

Nov 27, 2024

24 months ago

Wygant Jonathan

VP, Chief Accounting Officer

VP
Sell5.0K$42.89$216K

Nov 27, 2024

24 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell42.3K$-5032.00$0

Nov 19, 2024

24 months ago

Eastham Karin

Dir

Director
Sell14.7K$38.34$565K

Nov 19, 2024

24 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell18.5K$-14731.00$0

Nov 12, 2024

24 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell124.5K$-15275.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
VCYT Buy Conviction0%
Industry Rank#0 of 569
Volume Contribution0.2%
Total Industry Activity$16.52B

VCYT has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for VCYT

Over the last 90 days, corporate insiders at VCYT (VCYT) engaged in a total of 96 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 60 were sales. The total volume of insider trading reached $29.76M.

The net insider activity for VCYT shows a net selling bias of $29.76M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Stapley Marc (CEO), who traded 138.1K shares valued at $6.92M on Jun 4, 2026.

Live Market News & Developments
Aggregated real-time headlines for VCYT (VCYT)
6 updates

Veracyte, Inc. (VCYT) Stock Price, News, Quote & History

Yahoo! Finance Canada2d ago

Why Is Veracyte Stock Sinking Thursday?

Benzinga15d ago

VCYT - Veracyte Inc Stock Price and Quote

Finviz177d ago

Veracyte (VCYT) Stock Looks About Right After Cut Prostate Test Outlook

Simply Wall St6d ago

Veracyte (VCYT) Stock Still Looks Cheap As Its 107% Run Continues

Yahoo Finance43d ago

$VCYT stock is down 51% today. Here's what we see in our data.

Quiver Quantitative15d ago

FAQs About VCYT Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for VCYT.

Based on SEC Form 4 disclosures, the Insider Confidence Score for VCYT is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 60 sales by company executives over the last 90 days.

The CEO Conviction Index for VCYT is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.